2-(3-Pyridylmethyl)pyrazole-3-carboxylic acid, 98%, 1g

(2R,3R,4S,5R)-2-(4-AMINO-5-FLUORO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL, 90.0%, 500mg

(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid, 99.5%, 25g

4-Hydroxy-5,6,7,8-tetrahydroquinolin-2(1H)-one, 95.0%, 250mg

1-(1-Methoxypropan-2-yl)piperazine dihydrochloride, 95.0%, 5g

1-Chloro-3-(difluoromethyl)-2-fluorobenzene, 98.0%, 5g

Matraces de fondo redondo Matraces de doble cuello, 500 ml, 29/32, 1 Pieza

6-AMINO-1H-INDAZOLE-7-CARBOXYLIC ACID, 95%, 250mg

2-Chloro-6-ethoxypyridine-3-carboxylic acid, 95%, 5g

Espátulas dobles ROTILABO® micro, 150 mm, 3 mm, 1 Pieza

Metilchavicol, ROTICHROM® GC, 100 mg, envase de vidrio

Cuarzo, mínimo 99 % de polvo, hasta 125 µm, 5 kg, envase de plástico.

(S)-2-Amino-2-(4-fluoro-3-(trifluoromethyl)phenyl)ethanol hydrochloride, 95%, 250mg